Brennpunkt Pathologie in Lucerne
Our trusted supplier MS Validated Antibodies will be attending this year’s "Brennpunkt Pathologie" at Tagungszentrum Sankt Anna Stiftung in Lucerne. Join them for exciting presentations such as “Identification and evaluation of new and novel diagnostic markers using large scale tissue microarray resources” by Prof. Dr. med. Guido Sauter.
-
Our trusted supplier MS Validated Antibodies will be attending the 3rd advanced training event “Brennpunkt Pathologie” in Lucerne. This two-day symposium will focus on the latest updates in the classifications of head and neck pathology as well as gynecopathology, featuring presentations by renowned international experts who were instrumental in the development of these classifications. The program will include detailed insights into the 2023 WHO classifications, complemented by discussions on their impact on diagnostic practices in pathology.
Join MS Validated Antibodies for insightful presentations, lively discussions, and join exciting seminars including: “Identification and evaluation of new and novel diagnostic markers using large scale tissue microarray resources” by Prof. Dr. med. Guido Sauter.
Date: 16th - 17th January
Place: Tagungszentrum Sankt Anna Stiftung, Lucerne
Why chose MSVA?
- All MSVA antibodies have been validated for IHC on 76 different normal tissues.
- The analysis of all normal human tissue types enables the assessment of all human proteins and their post-translational modifications for cross-reactivity.
- Highly selective validation pipeline: Only 175 out of 7,000 antibodies have passed the tests and were selected for the MSVA portfolio.
- Unique antibody documentation on the MSVA website, featuring 60–100 images of relevant normal tissues and selected tumors.
- Documented performance characteristics of many antibodies in studies with over 10,000 tumors.